Altertox Academy trainings have been recognised by the SFT french society of toxicology as valuable for continuous professional development.
We invite key experts to present on the Thursday morning, these lectures are also available to watch as a webinar. Suppliers are invited to teach delegates to use their technologies for their own labs.
We are co-organising a scientific congress for Epithelix in Nice with more than 100 participants.
We want to have footprint outside Europe and happy to explore new opportunities via our new franchise. Ask our team
After organising 13 training sessions for 2017, what is new in 2018? We are having 6 lab trainings for toxicologists and 1 in life sciences sponsored by Axlr a french technology transfer acceleration company.
Altertox Academy is contributing in two granted projects by European Commission JRC EURL ECVAM with one of them is about building an inventory of worldwide 3Rs education & training resources
We are already working on 2019 training agenda. Feel free to contact if you want to host or join as an expert
4-5 October 2018
PBPK modelling for quantitative in vitro-in vivo extrapolation
KU - Leuven – Belgium // Prof. Pieter Annaert
+ info
Physiology-based (pharmaco)kinetic PB(P)K modelling has become a promising tool to predict plasma and/or tissue exposure to xenobiotics based on in vitro disposition data. While physiological parameters that characterize the target population have been largely implemented in several PB(P)K platforms, further consensus building is needed with respect to the quality requirements of in vitro data used for a successful bottom-up modelling approach. Therefore, this workshop will focus on improved integration of in vitro drug disposition assessments with the latest developments in the field of PB(P)K-based prediction. Special attention will also be given to prediction of (tissue) partition coefficients.
30-31 October 2018
Good Cell Culture Practice (GCCP) in Toxicology
Evercyte GmbH, Vienna – Austria // Regina Grillari
+ info
Draft Agenda Coming Soon
Participants will learn (among other things):
- about influence of culture conditions, age on cell performance
- standardised system set-up on angiogenisis in in vitro toxicology (primary vs. immortalised cell lines)
- about preparation of spheroids
and more to come!
Trainers are from Evercyte, AcCELLerate, Promega and Upcyte
8-9 November 2018
3DTissue Engineering Quality Control – From the bench to the bedside
IRMB, Montpellier - France // IRMB
+ info
This two days hands-on training will cover these topics and techniques in the lab:
• IPSC and reprogramming (R Desprat & JM Lemaitre – INSERM)
• Quality control of genetic stability: ” DNA integrity of IPSC by copy number variation by digital droplet PCR”(J Devos – stemgenomics)
• Gene expression profile: Arrays or RNA-seq? choosing the right tool for the job (V Pantesco, INSERM)
• 3D printing of hydrogels scaffolds. Design of scaffold, programation, printing parameters. (G Subra – Universite de Montpellier)
• Preclinical models of rheumatic disease: How to analyse bone and articular via imaging (D Noel, Ecellfrance)
15-16 November 2018
In Vitro Lung Models
Epithelix Sarl, Geneva – SWITZERLAND // S.Constant
+ info
This two-day hands-on training hosted by epithelix will cover practical use of respiratory in vitro 3D tissues and exposure devices to evaluate acute and repeated dose inhalation toxicity. To mimic systemic context, interconnection strategies of lung tissues will be presented.
22-23 November 2018
Skin Sensitization
BASF, Ludwigshafen – Germany // Barbara Birk
+ info
At this two days hands-on training, BASF experts will put emphasis on skin sensitization models such as h-clat (OECD TG 442E), DPRA (OECD TG 442C) and LuSens. In comparisons to 2017, this training will focus more intensely on the assessment of the data and testing strategies within the aforementioned models.
Eurosafe and immunosearch will also be part of the trainers in 2018
NOTE: The participation for this hands-on training requires preregistration. Please preregister according to sectors specified.
By the end of September all accepted and rejected participants who preregistered will be informed.